Literature DB >> 18430997

Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.

Zhihou Liang1, Fei Liu, Khalid Iqbal, Inge Grundke-Iqbal, Jerzy Wegiel, Cheng-Xin Gong.   

Abstract

Virtually all individuals with Down syndrome (DS) develop neurofibrillary tangles, a characteristic brain lesion of Alzheimer's disease (AD), when they reach the fourth decade of life. In AD, neurofibrillary tangles are thought to result from abnormal hyperphosphorylation of tau protein, which, in turn, can result from down-regulation of protein phosphatase (PP) 2A, a major brain tau phosphatase. The abnormal hyperphosphorylation of tau in DS had not yet been characterized, and its causes were not understood. In this study, by using quantitative Western blot analysis, we found that the level of the catalytic subunit of PP2A, but not of PP1, PP2B or PP5, was dramatically decreased. The decrease of PP2A level correlated negatively to tau level and tau phosphorylation at several abnormal hyperphosphorylation sites, including Ser199, Thr205, Thr212, Ser262, Ser396 and Ser422. Our results indicate that PP2A is down-regulated in DS brain and suggest that this down-regulation might be involved in the abnormal hyperphosphorylation and accumulation of tau.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430997      PMCID: PMC2655351          DOI: 10.3233/jad-2008-13307

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  38 in total

1.  Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains.

Authors:  J J Pei; C X Gong; K Iqbal; I Grundke-Iqbal; Q L Wu; B Winblad; R F Cowburn
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

2.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.

Authors:  A J Holland; J Hon; F A Huppert; F Stevens; P Watson
Journal:  Br J Psychiatry       Date:  1998-06       Impact factor: 9.319

3.  Differential susceptibility to neurofibrillary pathology among patients with Down syndrome.

Authors:  J Wegiel; H M Wisniewski; J Dziewiatkowski; E R Popovitch; M Tarnawski
Journal:  Dementia       Date:  1996 May-Jun

4.  Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A.

Authors:  E Sontag; V Nunbhakdi-Craig; G Lee; G S Bloom; M C Mumby
Journal:  Neuron       Date:  1996-12       Impact factor: 17.173

5.  Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus.

Authors:  Y Tatebayashi; K Iqbal; I Grundke-Iqbal
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

6.  Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase.

Authors:  M Goedert; R Jakes; Z Qi; J H Wang; P Cohen
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

7.  Phosphoprotein phosphatase activities in Alzheimer disease brain.

Authors:  C X Gong; T J Singh; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1993-09       Impact factor: 5.372

8.  The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.

Authors:  C A Lemere; J S Munger; G P Shi; L Natkin; C Haass; H A Chapman; D J Selkoe
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

9.  Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

Authors:  E Köpke; Y C Tung; S Shaikh; A C Alonso; K Iqbal; I Grundke-Iqbal
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

10.  Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain.

Authors:  C X Gong; S Shaikh; J Z Wang; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

View more
  22 in total

1.  Effect of PP-2A on neurite outgrowth in neuronal cells.

Authors:  Dan Liu; Hong-Yun Zheng; Zheng-Zhao Luo; Qun Wang; Ling-Qiang Zhu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-06-29       Impact factor: 2.416

2.  Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

Review 3.  mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.

Authors:  Fabio Di Domenico; Antonella Tramutola; Cesira Foppoli; Elizabeth Head; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2017-08-12       Impact factor: 7.376

Review 4.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

5.  Tau in Alzheimer's Disease: Pathological Alterations and an Attractive Therapeutic Target.

Authors:  Jian-Lan Gu; Fei Liu
Journal:  Curr Med Sci       Date:  2021-01-11

Review 6.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.

Authors:  Kwang-Jin Oh; Sylvia E Perez; Sarita Lagalwar; Laurel Vana; Lester Binder; Elliott J Mufson
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

Review 9.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

10.  Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage.

Authors:  Zhihou Liang; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.